SCHEMBL288704

SCHEMBL288704

C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)CC4C[C@H](OC(=O)CC[C@@H](C)[C@H]5CCC6C7CCC8CCCC[C@]8(C)C7CC[C@@]65C)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 4/20 0.72
NR1H4 Q96RI1 3/20 0.72
MEN1 O00255 3/20 0.70
KMT2A Q03164 3/20 0.70
LMNA P02545 2/20 0.70
TDP1 Q9NUW8 2/20 0.70
AKR1B10 O60218 1/20 0.70
AKR1B1 P15121 1/20 0.70
EFNA1 P20827 1/20 0.70
EPHA2 P29317 1/20 0.70
PSEN1 P49768 1/20 0.70
PSEN2 P49810 1/20 0.70
APH1B Q8WW43 1/20 0.70
NCSTN Q92542 1/20 0.70
APH1A Q96BI3 1/20 0.70
PSENEN Q9NZ42 1/20 0.70
HSD17B10 Q99714 1/20 0.70
USP2 O75604 1/20 0.66
VDR P11473 1/20 0.66
ABCB11 O95342 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL288122 1.00 GPBAR1 (0.72) GPBAR1NR1H4MEN1KMT2ALMNA
SCHEMBL23231215 1.00 GPBAR1 (0.72) GPBAR1NR1H4MEN1KMT2ALMNA
SCHEMBL23231228 0.94 GPBAR1 (0.81) GPBAR1NR1H4MEN1KMT2ALMNA
SCHEMBL288947 0.93 GPBAR1 (0.63) GPBAR1NR1H4MEN1KMT2ALMNA
SCHEMBL288629 0.93 EPHA2 (0.79) GPBAR1MEN1KMT2ALMNATDP1
SCHEMBL517850 0.91 GPBAR1 (0.74) GPBAR1NR1H4MEN1KMT2ALMNA
SCHEMBL2638871 0.91 GPBAR1 (0.74) GPBAR1NR1H4MEN1KMT2ALMNA
Ursodiol SCHEMBL288121 0.88 GPBAR1 (0.81) GPBAR1NR1H4MEN1KMT2ALMNA
Chenodiol SCHEMBL288703 0.88 GPBAR1 (0.81) GPBAR1NR1H4MEN1KMT2ALMNA
SCHEMBL23222858 0.88 GPBAR1 (0.82) GPBAR1NR1H4MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2449488-A1 METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES BIOCRATES Life Sciences AG (AT) 2012-05-09 EP disclosed
EP-2427773-A1 METHOD OF DIAGNOSING ASPHYXIA Keller, Matthias (DE) 2012-03-14 EP disclosed
WO-2011000753-A1 METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES BIOCRATES LIFE SCIENCES AG (AT) 2011-01-06 WO disclosed
WO-2010128054-A1 METHOD OF DIAGNOSING ASPHYXIA BIOCRATES LIFE SCIENCES AG (AT) 2010-11-11 WO disclosed